Pharmacoeconomic considerations in the health system management of anaemia in patients with chronic kidney disease and end stage renal disease

Author： Brophy Donald F   Ripley Elizabeth BD   Holdford David A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.9, 2003-09, pp. : 1461-1469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

By  

Current Drug Metabolism, Vol. 12, Iss. 1, 2011-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite

Approach to the management of end-stage renal disease

By Rodger R Stuart C  

Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. : 472-475

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacokinetics of Rosiglitazone in Patients with End-stage Renal Disease

By Thompson-Culkin K   Zussman B   Miller AK   Freed MI  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 391-399

Field House Publishing

Access to resources Recommend Favorite

Desmopressin: Safety Considerations in Patients with Chronic Renal Disease

By Sica Domenic A.   Gehr Todd W.B.  

Drug Safety, Vol. 29, Iss. 7, 2006-01 ,pp. : 553-556

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease

By Reese Jens P   Dams Judith   Winter Yaroslav   Balzer-Geldsetzer Monika   Oertel Wolfgang H   Dodel Richard  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 939-958

Informa Healthcare

Access to resources Recommend Favorite